Which ETFs hold GSK plc ORD GBP0.3125?
GSK is held by 40 of the 504 ETFs we cover. The heaviest allocation is SCHY at 3.6%; among the largest funds, VEA holds 0.4% and IEFA 0.4%. The median weight across all funds holding it is 0.4%. GSK plc ORD GBP0.3125 is classified Health Care.
- Covered ETFs Holding It
- 40
- Heaviest Allocation
- 3.58%in SCHY
- Median Weight
- 0.42%across funds that hold it
- Sector
- Health Care
Funds Holding GSK(40)
| ETF | |||||||
|---|---|---|---|---|---|---|---|
| SCHYSchwab International Dividend Equity ETF | 3.58% | 0.08% | $2.5B | 3.30% | +14.8% | +26.2% | +9.4% |
| EWUiShares MSCI United Kingdom ETF | 3.21% | 0.50% | $4.1B | 3.07% | +12.2% | +24.2% | +12.2% |
| IHDGWisdomTree International Hedged Quality Dividend Growth Fund | 2.15% | 0.58% | $2.2B | 1.77% | +12.1% | +22.6% | +7.8% |
| LVHIFranklin International Low Volatility High Dividend Index ETF | 1.81% | 0.40% | $5.5B | 4.49% | +18.9% | +33.8% | +16.9% |
| IXJiShares Global Healthcare ETF | 1.49% | 0.40% | $4.1B | 1.41% | +5.9% | +25.5% | +4.8% |
| DIHPDimensional International High Profitability ETF | 1.07% | 0.27% | $6.4B | 1.86% | +13.9% | +24.1% | — |
| IVLUiShares MSCI Intl Value Factor ETF | 1.00% | 0.31% | $4.5B | 3.16% | +18.8% | +35.6% | +15.9% |
| EFViShares MSCI EAFE Value ETF | 0.93% | 0.31% | $29.6B | 4.44% | +18.3% | +32.4% | +14.6% |
| IQLTiShares MSCI Intl Quality Factor ETF | 0.79% | 0.30% | $14.0B | 2.31% | +15.4% | +24.8% | +8.2% |
| BBEUJPMorgan BetaBuilders Europe ETF | 0.78% | 0.09% | $9.4B | 2.82% | +12.4% | +23.8% | +10.1% |
| IEURiShares Core MSCI Europe ETF | 0.68% | 0.10% | $9.1B | 3.05% | +12.6% | +22.8% | +9.3% |
| VGKVanguard European Stock Index Fund | 0.67% | 0.06% | $30.9B | 2.77% | +12.8% | +23.3% | +9.6% |
| EFAViShares MSCI EAFE Min Vol Factor ETF | 0.63% | 0.20% | $5.4B | 3.03% | +11.3% | +15.7% | +7.1% |
| VYMIVanguard International High Dividend Yield Index Fund | 0.57% | 0.07% | $21.1B | 3.43% | +19.1% | +32.7% | +14.2% |
| XTiShares Future Exponential Technologies ETF | 0.54% | 0.46% | $3.9B | 6.87% | +19.3% | +36.3% | +7.2% |
| BBINJPMorgan BetaBuilders International Equity ETF | 0.50% | 0.07% | $6.6B | 3.52% | +14.6% | +24.9% | +9.8% |
| EFAiShares MSCI EAFE ETF | 0.49% | 0.32% | $79.3B | 3.10% | +14.8% | +25.0% | +9.6% |
| DBEFXtrackers MSCI EAFE Hedged Equity ETF | 0.46% | 0.35% | $9.3B | 2.22% | +16.9% | +29.3% | +14.0% |
| IMTMiShares MSCI Intl Momentum Factor ETF | 0.43% | 0.30% | $4.2B | 4.34% | +12.9% | +21.7% | +10.1% |
| IEFAiShares Core MSCI EAFE ETF | 0.42% | 0.07% | $193.5B | 3.25% | +14.8% | +24.5% | +9.3% |
| ESGDiShares ESG Aware MSCI EAFE ETF | 0.42% | 0.20% | $12.2B | 3.18% | +15.1% | +24.6% | +9.3% |
| JIREJPMorgan International Research Enhanced Equity ETF | 0.39% | 0.24% | $11.2B | 2.61% | +14.5% | +24.4% | — |
| DFAIDimensional International Core Equity Market ETF | 0.39% | 0.18% | $17.5B | 2.24% | +15.2% | +26.8% | +10.7% |
| VEAVanguard Developed Markets Index Fund | 0.38% | 0.03% | $235.0B | 2.49% | +17.5% | +29.9% | +10.2% |
| IDEViShares Core MSCI International Developed Markets ETF | 0.37% | 0.04% | $31.8B | 3.08% | +14.8% | +25.5% | +9.7% |
Expense = net expense ratio from the fund's latest SEC prospectus filing. YTD/1Y/5Y are trailing total returns including dividends (5Y annualized, as of 2026-08-07). Past performance does not predict future results. Sort by any column.
Frequently Asked Questions
Which ETF has the most GSK exposure?
SCHY has the heaviest GSK allocation of the ETFs we cover, at 3.58% of its portfolio, based on the fund's latest SEC-reported holdings.
How many ETFs hold GSK?
40 of the 504 ETFs we cover hold GSK plc ORD GBP0.3125 (GSK). The median weight across those funds is 0.42%.
What is the cheapest ETF that holds GSK?
VEA has the lowest expense ratio among covered ETFs holding GSK, at 0.03% per year.
What is the largest ETF that holds GSK?
VEA (Vanguard Developed Markets Index Fund) is the largest covered ETF holding GSK, with $235.0B in assets and a 0.38% position.
Keep Exploring
Look up another stock or compare two of these ETFs to see how much they overlap beyond GSK.